What are the contraindications for Tramadol (tramadol hydrochloride)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tramadol Contraindications

Tramadol is contraindicated in patients with previous hypersensitivity to tramadol, any component of the product, or opioids, and in situations where opioids are contraindicated, including acute intoxication with alcohol, hypnotics, narcotics, centrally acting analgesics, opioids, or psychotropic drugs. 1

Absolute Contraindications

  • Hypersensitivity to tramadol, any component of the product, or opioids 1
  • Acute intoxication with alcohol, hypnotics, narcotics, centrally acting analgesics, opioids, or psychotropic drugs 1
  • Concomitant use of MAO inhibitors or use within 14 days of MAO inhibitor treatment (risk of potentially fatal interactions) 1
  • Children younger than 12 years (FDA contraindication) 2
  • Children younger than 18 years who are undergoing tonsillectomy and/or adenoidectomy (FDA contraindication) 2

Relative Contraindications and Cautions

Neurological Concerns

  • History of seizures or risk factors for seizures 1, 3
  • Concomitant use of medications that lower seizure threshold, including:
    • Selective serotonin reuptake inhibitors (SSRIs) 1
    • Tricyclic antidepressants (TCAs) 1
    • Other opioids 1
    • Neuroleptics 1
  • Risk of serotonin syndrome with concomitant use of:
    • SSRIs, SNRIs, TCAs 1, 3
    • MAOIs 1
    • Triptans 1
    • Drugs that impair metabolism of serotonin 1
    • CYP2D6 and CYP3A4 inhibitors 1

Respiratory Concerns

  • Respiratory depression risk (use with caution in at-risk patients) 1
  • Patients with increased intracranial pressure or head trauma 1
  • Adolescents aged 12-18 years who are obese or have conditions that increase risk of serious breathing problems (e.g., obstructive sleep apnea, severe lung disease) 2
  • Concomitant use with CNS depressants (use reduced dosages) 1, 4

Hepatic and Renal Concerns

  • Hepatic dysfunction (requires dose adjustment) 2
  • Renal dysfunction (requires dose adjustment) 4

Other Cautions

  • Patients with suicidal tendencies or addiction-prone individuals 1
  • Patients with emotional disturbance or depression 1
  • Patients taking tranquilizers or antidepressant drugs 1
  • Patients who use alcohol in excess 1
  • Patients with liver cirrhosis (bioavailability may increase 2-3 fold; limit to 50mg every 12 hours) 2

Special Populations

Pediatric Population

  • FDA guidelines contraindicate tramadol for:
    • Children younger than 12 years 2
    • Children and adolescents younger than 18 years after tonsillectomy and/or adenoidectomy 2
    • Caution in adolescents 12-18 years with risk factors for respiratory depression 2

Elderly Population

  • Higher risk for adverse effects from CNS depressants and tramadol combinations 4
  • May require dose adjustment due to age-related changes in metabolism 4

Monitoring and Management

  • Monitor for signs of respiratory depression, excessive sedation, and serotonin syndrome in patients on tramadol 4
  • Educate patients about signs of respiratory depression, excessive sedation, and serotonin syndrome 4
  • Use lowest effective dose when tramadol cannot be avoided in high-risk patients 4
  • Consider non-opioid analgesics (acetaminophen, NSAIDs) as alternatives for pain management when appropriate 4

Tramadol in Specific Conditions

  • Fibromyalgia: Tramadol has shown efficacy but carries risk of side effects and potential for abuse; careful monitoring required 2
  • Hepatocellular carcinoma with liver cirrhosis: Limited to 50mg within 12 hours due to increased bioavailability 2
  • Patients with seizure disorders: High risk of exacerbating seizures; alternative analgesics preferred 1, 3

Tramadol's unique mechanism as both a weak opioid agonist and a serotonin-norepinephrine reuptake inhibitor contributes to its efficacy but also to its distinct adverse effect profile and contraindications 3, 5. Understanding these contraindications is essential for safe prescribing practices.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures.

The American journal of medicine, 2018

Guideline

Safety of Taking Tramadol with Quetiapine and Lorazepam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Pharmacology of tramadol].

Drugs, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.